Sign In
Buy MMC
$182.70
+0 (+0%)
At Close: Apr 10, 2026
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2022 Update
04:49am, Monday, 06'th Jun 2022 Seeking Alpha
Halvorsen's 13F portfolio value decreased from $34.49B to $24.74B this quarter. The top 3 positions are T-Mobile US, Amazon.com, and General Electric, together, at ~16% of the portfolio.
Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2022
02:08pm, Friday, 03'rd Jun 2022 Benzinga
Upgrades
Keefe, Bruyette & Woods upgraded the previous rating for Regions Financial Corp (NYSE:RF) from Underperform to Market Perform. For the first quarter, Regions Financial had an EPS of $0.55, c
Marsh & McLennan (MMC) Up 13.6% in a Year: More Room to Rally?
06:32pm, Friday, 27'th May 2022 Zacks Investment Research
Marsh & McLennan's (MMC) solid Risk and Insurance Services business is a major driver.
Marsh & McLennan (MMC) Up 13.6% in a Year: More Room to Rally?
03:49pm, Friday, 27'th May 2022
Marsh & McLennan's (MMC) solid Risk and Insurance Services business is a major driver.
Analyst Ratings for Marsh & McLennan
06:03pm, Monday, 23'rd May 2022 Benzinga
Over the past 3 months, 8 analysts have published their opinion on Marsh & McLennan (NYSE:MMC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a c
Marsh & McLennan: Trees Don't Grow To The Sky, But Brokers Might
01:46pm, Friday, 13'th May 2022
Marsh & McLennan is the top insurance broker and a rare example of a successful serial acquirer. Margins have expanded impressively in the last decade, overcoming a soft insurance market most of the t
Zacks Industry Outlook Highlights Marsh & McLennan, Aon, Arthur J. Gallagher, Willis Tower Watson, and Brown & Brown
01:06pm, Friday, 13'th May 2022 Zacks Investment Research
Marsh & McLennan, Aon, Arthur J. Gallagher, Willis Tower Watson, and Brown & Brown are part of Zacks Industry Outlook article.
5 Insurance Brokers Benefiting From Rising Demand
02:21pm, Thursday, 12'th May 2022 Zacks Investment Research
Increased demand for insurance products, given an aging population, baby boomers and millennials and the adoption of technology should drive insurance brokers like MMC, AON, AJG, WTW and BRO.
5 Insurance Brokers Benefiting From Rising Demand
12:03pm, Thursday, 12'th May 2022
Increased demand for insurance products, given an aging population, baby boomers and millennials and the adoption of technology should drive insurance brokers like MMC, AON, AJG, WTW and BRO.
Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2022
02:04pm, Tuesday, 03'rd May 2022 Benzinga
Upgrades
For SVB Financial Group (NASDAQ:SIVB), Oppenheimer upgraded the previous rating of Perform to Outperform. For the first quarter, SVB Finl Gr had an EPS of $7.92, compared to year-ago quarter
10 Biggest Price Target Changes For Tuesday
12:36pm, Tuesday, 03'rd May 2022 Benzinga
Morgan Stanley cut Expedia Group, Inc. (NASDAQ: EXPE) price target from $215 to $210. Expedia shares rose 0.1% to close at $174.81 on Monday.
Oppenheimer cut the price target for EverQuote, Inc. (
The Zacks Analyst Blog Highlights Novo Nordisk, Advanced Micro Devices, Netflix, Merck, and Marsh & McLennan
10:39am, Wednesday, 27'th Apr 2022 Zacks Investment Research
Novo Nordisk, Advanced Micro Devices, Netflix, Merck, and Marsh & McLennan have been included in this Analyst Blog.
Top Research Reports for Novo Nordisk, AMD & Netflix
09:20pm, Tuesday, 26'th Apr 2022 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), Advanced Micro Devices, Inc. (AMD), and Netflix, Inc. (NFLX).
Analyst Ratings for Marsh & McLennan
08:10pm, Friday, 22'nd Apr 2022 Benzinga
Within the last quarter, Marsh & McLennan (NYSE:MMC) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
0
2
5
0
0
Last 3
Raymond James Maintains Outperform Rating for Marsh & McLennan: Here's What You Need To Know
04:31pm, Friday, 22'nd Apr 2022 Benzinga
Raymond James has decided to maintain its Outperform rating of Marsh & McLennan (NYSE:MMC) and raise its price target from $185.00 to $190.00.
Shares of Marsh & McLennan are trading down 3.2% over the
